UK vaccine panel says under-30s should not receive Oxford/AstraZeneca vaccine
UK vaccine panel says under-30s should not receive Oxford/AstraZeneca vaccine
"Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available," said Wei Shen Lim, COVID-19 Chair for JCVI.
(Reporting by Alistair Smout, Guy Faulconbridge and Kate
Holton; editing by James Davey)
((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters
Messaging: alistair.smout.thomsonreuters.com@reuters.net)
LONDON, April 7 (Reuters) - Britain should not give Oxford University/AstraZeneca's vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain.
"Based on the available data and evidence, JCVI has advised that it is preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available," said Wei Shen Lim, COVID-19 Chair for JCVI.
(Reporting by Alistair Smout, Guy Faulconbridge and Kate
Holton; editing by James Davey)
((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters
Messaging: alistair.smout.thomsonreuters.com@reuters.net)
倫敦，4月7日(路透社)-英國疫苗接種和免疫聯合委員會(JCVI)週三表示，英國不應該在可能的情況下給30歲以下的人接種牛津大學/阿斯利康的疫苗，因為大腦中的血栓是非常罕見的副作用。JCVI新冠肺炎主席林偉(音譯)表示：“根據現有的數據和證據，JCVI建議，對於30歲以下、沒有潛在疾病的成年人，在可用的情況下，最好為他們提供阿斯利康疫苗的替代品。”(Alistair Smout，Guy Faulconbridge和Kate報道(Holton；James Davey編輯)(alistair.smout@thomsonreurs.com；+44 207 542 7064；路透社消息：alistair.smout.thomsonreuters.com@reuters.net)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧